Alison E. Obr
Impact in
-
- Estrogen and related hormone effects
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Risks and Factors
Papers in
- Genetics 6
- Estrogen and related hormone effects 5
- Inflammatory Bowel Disease 1
-
- Growth Hormone and Insulin-like Growth Factors 2
- Co-authors
- Dean P. Edwards (5 shared papers)Teresa L. Wood (5 shared papers)Sandra L. Grimm (4 shared papers)Sushil Kumar (2 shared papers)Raymond B. Birge (2 shared papers)John P. Lydon (3 shared papers)John Wesley Pike (1 shared paper)Kathleen A. Bishop (2 shared papers)
- Journals
- Molecular Endocrinology (3 papers)Frontiers in Immunology (1 paper)Carcinogenesis (1 paper)Molecular and Cellular Endocrinology (1 paper)Journal of Chemotherapy (1 paper)
- Partner nations
- United StatesIrelandChina
In The Last Decade
Alison E. Obr
12 papers receiving 345 citations
Peers
Comparison fields: 5 of 37
- Genetics 76
- Oncology 51
- Cancer Research 25
- Endocrinology, Diabetes and Metabolism 21
- Health, Toxicology and Mutagenesis 13
Countries citing papers authored by Alison E. Obr
This map shows the geographic impact of Alison E. Obr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison E. Obr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison E. Obr more than expected).
Fields of papers citing papers by Alison E. Obr
This network shows the impact of papers produced by Alison E. Obr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison E. Obr. The network helps show where Alison E. Obr may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison E. Obr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 143 | |
| 2 | 2013 | 51 | |
| 3 | 2017 | 42 | |
| 4 | 2018 | 39 | |
| 5 | 2011 | 25 | |
| 6 | 2019 | 16 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 8 | |
| 9 | 2020 | 7 | |
| 10 | 2008 | 5 | |
| 11 | 2014 | 5 | |
| 12 | 2011 | 1 |
About Alison E. Obr
Alison E. Obr is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Infectious Diseases and Oncology, having authored 12 papers that have together received 354 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (5 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Inflammatory Bowel Disease (1 paper), Antifungal resistance and susceptibility (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), RNA Research and Splicing (1 paper) and Multiple Sclerosis Research Studies (1 paper). The work is most often cited by research in Genetics (76 citations), Oncology (51 citations), Cancer Research (25 citations), Endocrinology, Diabetes and Metabolism (21 citations) and Health, Toxicology and Mutagenesis (13 citations). Alison E. Obr has collaborated with scholars based in United States, Ireland and China. Frequent co-authors include Dean P. Edwards, Teresa L. Wood, Sandra L. Grimm, Sushil Kumar, Raymond B. Birge, John P. Lydon, John Wesley Pike, Kathleen A. Bishop, Viralkumar Davra and Mariana S. De Lorenzo. Their work appears in journals such as Molecular Endocrinology, Frontiers in Immunology, Carcinogenesis, Molecular and Cellular Endocrinology and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.